2015 - 2021 were the glory days. ton of business, growth, no competition, lucky and struck lightning after a government mandated tech solution in the pharma market. Present day..... increased competition, multiple scrapped new product launches, saturated market with capped growth potential, market share decline, leaders with huge egos disconnected from the market and with a big yet unrealistic vision, micro-managing & bullying of subordinates, closed off to employee feedback, dozens of key employees continuously departing "revolving door", a toxic "only tell me what I want to hear!" work culture, some "inner circle" nepotism and then older employees hiding under the radar just long enough until they can retire, client churn, etc. Nothing will change unless the Board steps in for a regime change. Best thing would be for a big tech player to acquire the company and add it to their pharma platform portfolio as a niche solution to check that box. Sad but honest and candid snapshot. This isn't a disgruntled employee review. Outlook is full of hurdles, landmines, and gloom. For your consideration only. Its your call.